Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD5004 Interaction With Mitiglinide and Pioglitazone in Healthy Participants
jRCT2071250139Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of elecoglipron (4 arms), sponsored by AstraZeneca. Primary endpoints: AUCinf, AUClast and 1 more. Started Mar 2026; status: completed.
02
Drugs
elecoglipron
Beyond the preview
Go deeper on jRCT2071250139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071250139.